Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide MeSH Supplementary Concept Data 2026


MeSH Supplementary
N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide
Unique ID
C512204
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C512204
Entry Term(s)
Sch 503034
Sch-503034
Sch503034
boceprevir
victrelis
Registry Numbers
89BT58KELH
Heading Mapped to
Proline / analogs & derivatives
Frequency
606
Note
Sch-503034 is the (1R,2S,5S)-isomer; an HCV protease inhibitor; structure in first source
Source
Antiviral Res 2006 Jun;70(2):28-38
Date Introduced
2006/08/02
Last Updated
2016/08/31
N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide Preferred
Sch 503034 Narrower
victrelis Narrower
page delivered in 0.008s